Who
Michael E. Fortin
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Natural Alternatives International.
In numbers
- Trades disclosed
- 35
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $345K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Oct 2015
- Last trade
- 6 Mar 2026
- Last filed
- 10 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Mar 2026filed 10 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code F | $12K4,308 at $2.73 | filing |
| 6 Mar 2026filed 10 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code F | $12K4,308 at $2.73 | filing |
| 6 Mar 2026filed 10 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 7 Mar 2025filed 11 Mar 2025 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code F | $24K6,346 at $3.84 | filing |
| 8 Mar 2024filed 11 Mar 2024 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 7 Mar 2024filed 11 Mar 2024 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code F | $32K5,319 at $5.95 | filing |
| 7 Mar 2023filed 9 Mar 2023 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —11,000 at $0.00 | filing |
| 7 Mar 2023filed 9 Mar 2023 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code F | $29K3,255 at $8.86 | filing |
| 7 Mar 2022filed 8 Mar 2022 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code F | $43K3,869 at $11.00 | filing |
| 15 Mar 2021filed 18 Mar 2021 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —6,500 at $0.00 | filing |
| 12 Mar 2021filed 12 Mar 2021 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Sold | $83K5,020 at $16.45 | filing |
| 11 Mar 2021filed 12 Mar 2021 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Sold | $150K9,201 at $16.26 | filing |
| 8 Mar 2021filed 10 Mar 2021 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code F | $78K5,174 at $15.05 | filing |
| 4 Mar 2021filed 8 Mar 2022 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —11,000 at $0.00 | filing |
| 1 Mar 2021filed 2 Mar 2021 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Sold | $65K3,950 at $16.37 | filing |
| 26 Feb 2021filed 2 Mar 2021 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Sold | $34K2,086 at $16.49 | filing |
| 16 Nov 2020filed 18 Nov 2020 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Sold | $14K1,375 at $10.35 | filing |
| 1 Oct 2020filed 5 Oct 2020 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code F | $18K2,479 at $7.40 | filing |
| 17 Apr 2020filed 27 Apr 2020 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code J | —15,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.